These supplements carry real danger.
at worst. Recently, the Food and Drug Administration issued warnings about three supplements that could pose serious health risks. Read on to see which recalled products are causing the agency concern and what you should do if you've purchased them.On Feb. 8, the FDA announced that three male enhancement supplements are being voluntarily recalled by their respective manufacturers.
. The affected product is packaged in 10-count blister packs within a carton printed with lot number 26436989 and an expiration date of 10/30/2023. The Red Pill was also distributed and sold through Amazon nationwide.The product recalls were issued when it was discovered that the supplements contained undeclared ingredients that could pose health risks to some people taking them.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Addressing Ongoing COVID-19 Vaccine Questions With CDC and FDA ExpertsJoin COVIDVxProject on 2/10 at 11:30 am ET for an informative webinar addressing COVID19 vaccine questions. Hear directly from the CDCDirector, FDACBER's Dr. Peter Marks, and CDCgov’s Dr. Sara Oliver. RSVP to secure your spot.
Read more »
COVID test recall 2022: Which at-home tests does FDA recommend using?At-home COVID-19 tests are a key part of America's pandemic response but the FDA urges people to only use authorized tests to avoid false negatives.
Read more »
If You Have Any of These Ice Creams, Throw Them Out Now, FDA Warns — Best LifeMultiple flavors of Batch Ie Cream are being recalled due to possible listeria contamination, which can be deadly.
Read more »
US preps 10 million doses of COVID-19 vaccine for kids under 5, pending FDA authorizationCOVID-19 vaccines for kids under 5 have not yet been authorized, but the rollout plan is already in the works.
Read more »
Young kids’ COVID vaccines create approval dilemma for FDATwo doses of Pfizer's vaccine showed mixed results in trials, but the agency is considering approving it anyways in anticipation that a future third shot will provide children with strong immunity.
Read more »
FDA Advisers Say Agency Shouldn’t Approve China-Developed Cancer Drug NowA panel advising U.S. drug regulators said Eli Lilly and Co. and its Chinese partner should conduct more studies of a proposed new lung-cancer drug before approval because of concerns about the medicine’s testing in China.
Read more »